[1] |
VAN SMAALEN TC, BEURSKENS DM, HOOGLAND ER, et al. Presence of cytotoxic extracellular histones in machine perfusate of donation after circulatory death kidneys[J]. Transplantation, 2017, 101(4): e93-e101. DOI: 10.1097/TP.0000000000001590.
|
[2] |
VAN DEN AKKER EK, HESSELINK DA, MANINTVELD OC, et al. Neutrophil gelatinase-associated lipocalin, but not kidney injury marker 1, correlates with duration of delayed graft function[J]. Eur Surg Res, 2015, 55(4): 319-327. DOI: 10.1159/000440718.
|
[3] |
PARIKH CR, HALL IE, BHANGOO RS, et al. Associations of perfusate biomarkers and pump parameters with delayed graft function and deceased donor kidney allograft function[J]. Am J Transplant, 2016, 16(5): 1526-1539. DOI: 10.1111/ajt.13655.
|
[4] |
GAVRⅡLIDIS P, INSTON NG. Recipient and allograft survival following donation after circulatory death versus donation after brain death for renal transplantation: a systematic review and Meta-analysis[J]. Transplant Rev (Orlando), 2020, 34(4): 100563. DOI: 10.1016/j.trre. 2020.100563.
|
[5] |
BUTALA NM, REESE PP, DOSHI MD, et al. Is delayed graft function causally associated with long-term outcomes after kidney transplantation? instrumental variable analysis[J]. Transplantation, 2013, 95(8): 1008-1014. DOI: 10.1097/TP.0b013e3182855544.
|
[6] |
LIM WH, JOHNSON DW, TEIXEIRA-PINTO A, et al. Association between duration of delayed graft function, acute rejection, and allograft outcome after deceased donor kidney transplantation[J]. Transplantation, 2019, 103(2): 412-419. DOI: 10.1097/TP.0000000000002275.
|
[7] |
BAHL D, HADDAD Z, DATOO A, et al. Delayed graft function in kidney transplantation[J]. Curr Opin Organ Transplant, 2019, 24(1): 82-86. DOI: 10.1097/MOT.0000000000000604.
|
[8] |
MIRET ALOMAR E, TRILLA HERRERA E, LORENTE GARCIA D, et al. Systematic review of kidney transplantation functional predictors[J]. Actas Urol Esp, 2018, 42(4): 218-226. DOI: 10.1016/j.acuro.2017.07.004.
|
[9] |
KIEVIT JK, NEDERSTIGT AP, OOMEN AP, et al. Release of alpha-glutathione S-transferase (alpha GST) and pi-glutathione S-transferase (pi GST) from ischemic damaged kidneys into the machine perfusate--relevance to viability assessment[J]. Transplant Proc, 1997, 29(8): 3591-3593. DOI: 10.1016/s0041-1345(97)01036-1.
|
[10] |
VANMASSENHOVE J, VANHOLDER R, NAGLER E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature[J]. Nephrol Dial Transplant, 2013, 28(2): 254-273. DOI: 10.1093/ndt/gfs380.
|
[11] |
QURASHI S, GHAMDI G, JARADAT M, et al. Urinary neutrophil gelatinase-associated lipocalin and the occurrence of delayed graft function after kidney transplant[J]. Exp Clin Transplant, 2014, 12(5): 396-400. DOI: 10.6002/ect.2013.0300.
|
[12] |
GARCIA-ALVAREZ M, GLASSFORD NJ, BETBESE AJ, et al. Urinary neutrophil gelatinase-associated lipocalin as predictor of short- or long-term outcomes in cardiac surgery patients[J]. J Cardiothorac Vasc Anesth, 2015, 29(6): 1480-1488. DOI: 10.1053/j.jvca.2015.05.060.
|
[13] |
GÓMEZ-DOS-SANTOS V, RAMOS-MUÑOZ E, GARCÍA-BERMEJO ML, et al. MicroRNAs in kidney machine perfusion fluid as novel biomarkers for graft function. normalization methods for miRNAs profile analysis[J]. Transplant Proc, 2019, 51(2): 307-310. DOI: 10.1016/j.transproceed.2018.09.019.
|
[14] |
LI YM, LI Y, YAN L, et al. Comparison of urine and blood NGAL for early prediction of delayed graft function in adult kidney transplant recipients: a Meta-analysis of observational studies[J]. BMC Nephrol, 2019, 20(1): 291. DOI: 10.1186/s12882-019-1491-y.
|
[15] |
QUINTELLA AHDS, LASMAR MF, FABRETI-OLIVEIRA RA, et al. Delayed graft function, predictive factors, and 7-year outcome of deceased donor kidney transplant recipients with different immunologic profiles[J]. Transplant Proc, 2018, 50(3): 737-742. DOI: 10.1016/j.transproceed.2018.02.007.
|
[16] |
MOERS C, VARNAV OC, VAN HEURN E, et al. The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome[J]. Transplantation, 2010, 90(9): 966-973. DOI: 10.1097/TP.0b013e3181f5c40c.
|
[17] |
HOOGLAND ER, DE VRIES EE, CHRISTIAANS MH, et al. The value of machine perfusion biomarker concentration in DCD kidney transplantations[J]. Transplantation, 2013, 95(4): 603-610. DOI: 10.1097/TP.0b013e31827908e6.
|
[18] |
DE KOK MJC, SCHAAPHERDER AFM, ALWAYN IPJ, et al. Improving outcomes for donation after circulatory death kidney transplantation: science of the times[J]. PLoS One, 2020, 15(7): e0236662. DOI: 10.1371/journal.pone.0236662.
|
[19] |
CHEN R, WANG H, SONG L, et al. Predictors and one-year outcomes of patients with delayed graft function after deceased donor kidney transplantation[J]. BMC Nephrol, 2020, 21(1): 526. DOI: 10.1186/s12882-020-02181-1.
|
[20] |
WALLS DO, LEE-RIDDLE GS, BOVER MANDERSKI M, et al. Kidney transplant outcomes from donation after circulatory death donors of advanced age[J]. Clin Transplant, 2020, 34(7): e13881. DOI: 10.1111/ctr.13881.
|
[21] |
NASHAN B, ABBUD-FILHO M, CITTERIO F. Prediction, prevention, and management of delayed graft function: where are we now?[J]. Clin Transplant, 2016, 30(10): 1198-1208. DOI: 10.1111/ctr.12832.
|
[22] |
SAHRAEI Z, SALAMZADEH J, NAFAR M. Effect of N-acetyl cysteine and vitamin C on kidney allograft function biomarkers interleukin-18 and neutrophil gelatinase-associated lipocalin[J]. Iran J Kidney Dis, 2015, 9(1): 56-62.
|
[23] |
YADAV B, PRASAD N, AGRAWAL V, et al. Urinary kidney injury molecule-1 can predict delayed graft function in living donor renal allograft recipients[J]. Nephrology (Carlton), 2015, 20(11): 801-806. DOI: 10.1111/nep.12511.
|
[24] |
KOSTIDIS S, BANK JR, SOONAWALA D, et al. Urinary metabolites predict prolonged duration of delayed graft function in DCD kidney transplant recipients[J]. Am J Transplant, 2019, 19(1): 110-122. DOI: 10.1111/ajt.14941.
|
[25] |
LI F, HU L, ZHAO X, et al. The value of cystatin C and urinary and serum neutrophil gelatinase-associated lipocalin during the perioperative period of renal transplantation[J]. Transl Androl Urol, 2019, 8(5): 432-441. DOI: 10.21037/tau.2019.08.12.
|
[26] |
TRUCHE AS, TROCME C, VERGNAUD S, et al. Early prediction of graft outcomes after kidney transplantation from donors after circulatory death: biomarkers and transplantation characteristics[J]. Transplant Proc, 2019, 51(10): 3234-3243. DOI: 10.1016/j.transproceed.2019.09.009.
|
[27] |
WILLIAMS KR, COLANGELO CM, HOU L, et al. Use of a targeted urine proteome assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant[J]. Proteomics Clin Appl, 2017, 11(7/8). DOI: 10.1002/prca.201600132.
|
[28] |
HAMAR M, SELZNER M. Ex-vivo machine perfusion for kidney preservation[J]. Curr Opin Organ Transplant, 2018, 23(3): 369-374. DOI: 10.1097/MOT.0000000000000524.
|
[29] |
CAPPUCCILLI M, CAPELLI I, COMAI G, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of allograft function after renal transplantation: evaluation of the current status and future insights[J]. Artif Organs, 2018, 42(1): 8-14. DOI: 10.1111/aor.13039.
|
[30] |
MOSER MAJ, SAWICKA K, ARCAND S, et al. Proteomic analysis of perfusate from machine cold perfusion of transplant kidneys: insights into protection from injury[J]. Ann Transplant, 2017, 22: 730-739. DOI: 10.12659/aot.905347.
|
[31] |
VAN SMAALEN TC, HOOGLAND ER, VAN HEURN LW. Machine perfusion viability testing[J]. Curr Opin Organ Transplant, 2013, 18(2): 168-173. DOI: 10.1097/MOT.0b013e32835e2a1b.
|
[32] |
KOO TY, JEONG JC, LEE Y, et al. Pre-transplant evaluation of donor urinary biomarkers can predict reduced graft function after deceased donor kidney transplantation[J]. Medicine (Baltimore), 2016, 95(11): e3076. DOI: 10.1097/MD.0000000000003076.
|